The transfer of stool from a healthy donor into the gastrointestinal tract of a recipient (FMT) at first consideration does not seem like a reasonable or scientific approach to the treatment of gastrointestinal diseases. Historically however, it has been used by communities for over 3,000 years, gaining credibility in 1958 after a paper by Eisemen in Denver who described treating pseudomembranous colitis this way. More recently double-blind randomised control trials have demonstrated the efficacy of FMT in the treatment of severe clostridium difficile enterocolitis. To discuss this subject in more detail we are joined in a conversation with Dr Darcy Holt, senior consultant at Monash Health, who also works at the Centre for GI Health, as he leads us through –
· The indications for FMT
· Therapeutic advantages
· Practical aspects of FMT
With his typical academic flare and clarity of dialogue, please enjoy this interesting conversation with Darcy.
Useful references include –
To be a guest on the show or provide some feedback, I’d love to hear from you: manager@gihealth.com.au
Dr Luke Crantock MBBS, FRACP, is a gastroenterologist in practice for over 25 years. He is the founder of The Centre for GI Health, based in Melbourne Australia and is passionate about educating General Practitioners and patients on disease prevention and how to manage and improve their digestive health.
